|
Dr. McKim graduated with high honors in 1989 from the doctoral program in biochemical and molecular toxicology at Oregon State University. He then continued his training at the University of Kansas Medical School as a postdoctoral fellow in the laboratory of Dr. Curtis Klaassen, a well-known scientist and a leader in the field of toxicology. During this time, Dr. McKim was awarded the Postdoctoral Outstanding Research Award and was recognized by the Society of Toxicology. Following his three years in Kansas, Dr. McKim accepted a position with the University of Colorado School of Medicine, in the pediatric GI group. His research there focused on the mechanisms underlying children’s liver diseases. In 1993 Dr. McKim accepted a biochemical toxicologist position with Dow Corning in Midland, Michigan. His primary responsibility was to lead research designed to understand the biological effects of silicone products. For these efforts, Dr. McKim was awarded the Dow Corning Technical Achievement Award for Research. From Dow Corning, Dr. McKim moved to Kalamazoo, Michigan in 1998, in order to accept a position with Pharmacia Corporation. During his stint at Pharmacia, Dr. McKim led an initiative to develop and implement in vitro screening technologies that would allow discovery teams to identify and understand potential adverse effects of new drug candidates early in the development process. Dr. McKim received the Preclinical Impact Award in 2002 for leading the industry with these initiatives. In 2003, he was promoted to senior research advisor and was admitted into the prestigious scientific fellow program as a full scientific fellow. Over his career, Dr. McKim has published many scientific manuscripts, book chapters, and reviews. Dr. McKim is a diplomat of the American Board of Toxicology and served as President of the Michigan Society of Toxicology in 2005. Dr. McKim is currently the founder, president, and CEO of CeeTox, Inc. in Kalamazoo, MI. | 